← Leaderboards
Eileen S Carpenter
Veterans Health Administration
$107,127
Attributed
$107,127
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2012–25$50K$37.5K$25K$12.5K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$107,127 · 1
VA$0 · 1
By mechanism
F30$107,127 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Veterans Health Administration
Same institution · by research overlap
- Judith Ann Callan$357,174
- Ling Gao$1,511,555
- Richard Altschuler$0
- Ambra Pozzi$8,402,682
- Nancy Grace Klimas$2,908,659
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresHeterogeneityReportingResistanceChemotherapyCancer EtiologyMalignant Neoplasm Of PancreasPancreatic Ductal AdenocarcinomaTumorTherapeutic TargetMediatingDiagnosisConsentData SetCoculture TechniquesCytometryDiagnosticClinicCellsBiometryBiopsyCessation Of LifeBloodAggressive Behavior
Grant awards (7)
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance$0
IK2 · FY2025 · VA · contact PI
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance$0
IK2 · FY2024 · VA · contact PI
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance$0
IK2 · FY2023 · VA · contact PI
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance$0
IK2 · FY2022 · VA · contact PI
Defining PI3K p110alpha as a therapeutic target in pancreatic cancer$45,541
F30 · FY2014 · CA · contact PI
Defining PI3K p110alpha as a therapeutic target in pancreatic cancer$30,793
F30 · FY2013 · CA · contact PI
Defining PI3K p110alpha as a therapeutic target in pancreatic cancer$30,793
F30 · FY2012 · CA · contact PI